Repro Med Systems, Inc. (KRMD) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
100 CORPORATE DRIVE MAHWAH, NJ 07430 |
| State of Incorp. | NY |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 2/28/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 17,408 | 25,335 | 27,315 | 5,871 | 3,739 | 3,313 | |||
| Cash and cash equivalents | 17,408 | 25,335 | 27,315 | 5,871 | 3,739 | 3,313 | |||
| Receivables | 3,559 | 3,593 | 2,573 | 3,235 | 1,426 | 172 | |||
| Inventory, net of allowances, customer advances and progress billings | 6,405 | 6,106 | 6,830 | 2,388 | 2,104 | 1,354 | |||
| Inventory | 6,405 | 6,106 | 6,830 | 2,388 | 2,104 | 1,354 | |||
| Prepaid expense | 1,457 | 1,569 | 808 | 387 | 247 | 176 | |||
| Other undisclosed current assets | 972 | 718 | 1,518 | 1,764 | |||||
| Total current assets: | 29,802 | 37,321 | 37,526 | 11,881 | 9,033 | 6,780 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 3,787 | 96 | 237 | 374 | ✕ | ✕ | |||
| Property, plant and equipment | 3,887 | 1,106 | 1,168 | 612 | 859 | 932 | |||
| Intangible assets, net (including goodwill) | 787 | 809 | 844 | 807 | 632 | 427 | |||
| Intangible assets, net (excluding goodwill) | 787 | 809 | 844 | 807 | 632 | 427 | |||
| Deferred income tax assets | 3,967 | 1,941 | 125 | ✕ | ✕ | ||||
| Other noncurrent assets | 103 | 20 | 20 | 20 | 20 | 31 | |||
| Deferred tax assets, net | ✕ | ✕ | ✕ | ✕ | ✕ | 1 | |||
| Other undisclosed noncurrent assets | 188 | ||||||||
| Total noncurrent assets: | 12,531 | 3,972 | 2,393 | 2,001 | 1,512 | 1,391 | |||
| TOTAL ASSETS: | 42,332 | 41,293 | 39,919 | 13,882 | 10,545 | 8,170 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 5,282 | 4,098 | 3,522 | 2,264 | 1,580 | 1,367 | |||
| Taxes payable | ✕ | ✕ | 205 | 17 | |||||
| Employee-related liabilities | ✕ | ✕ | 161 | 287 | 190 | 422 | 177 | ||
| Accounts payable | 2,392 | 1,228 | 625 | 573 | 453 | 772 | |||
| Accrued liabilities | 2,890 | 2,710 | 2,610 | 1,297 | 689 | 417 | |||
| Debt | 532 | 509 | 3 | 142 | |||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 22 | ||
| Deferred lease income | ✕ | ✕ | ✕ | 4 | ✕ | ||||
| Other liabilities | 257 | ||||||||
| Other undisclosed current liabilities | 888 | 186 | 141 | ||||||
| Total current liabilities: | 6,959 | 4,792 | 3,666 | 2,406 | 1,584 | 1,389 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 394 | 96 | 239 | ||||||
| Finance lease, liability | 394 | 3 | ✕ | ✕ | |||||
| Liabilities, other than long-term debt | 3,653 | 105 | |||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 22 | ||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | ✕ | 82 | |||
| Operating lease, liability | 3,653 | 96 | 237 | ✕ | ✕ | ||||
| Other undisclosed noncurrent liabilities | (96) | ||||||||
| Total noncurrent liabilities: | 4,048 | 96 | 239 | 105 | |||||
| Total liabilities: | 11,006 | 4,792 | 3,762 | 2,646 | 1,584 | 1,494 | |||
| Equity | |||||||||
| Equity, attributable to parent | 31,326 | 36,501 | 36,157 | 11,236 | 8,961 | 6,676 | |||
| Common stock | 489 | 480 | 467 | 422 | 409 | 406 | |||
| Treasury stock, value | (3,844) | (3,844) | (3,844) | (344) | (344) | (344) | |||
| Additional paid in capital | 44,252 | 40,774 | 35,881 | 6,293 | 4,595 | 4,130 | |||
| Retained earnings (accumulated deficit) | (9,571) | (910) | 3,653 | 4,865 | 4,300 | 2,485 | |||
| Total equity: | 31,326 | 36,501 | 36,157 | 11,236 | 8,961 | 6,676 | |||
| TOTAL LIABILITIES AND EQUITY: | 42,332 | 41,293 | 39,919 | 13,882 | 10,545 | 8,170 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 2/28/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 27,896 | 23,490 | 24,176 | 23,163 | 17,354 | 12,294 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 12,294 | |
| Cost of revenue (Cost of Goods and Services Sold) | (12,527) | (9,721) | (9,240) | (8,309) | (6,543) | (4,724) | ||
| Gross profit: | 15,369 | 13,770 | 14,936 | 14,854 | 10,810 | 7,570 | ||
| Operating expenses | (26,150) | (20,799) | (16,191) | (14,268) | (9,646) | (8,306) | ||
| Operating income (loss): | (10,781) | (7,030) | (1,255) | 586 | 1,165 | (736) | ||
| Nonoperating income (expense) | 106 | 665 | 61 | 63 | 7 | (39) | ||
| Gain (loss), foreign currency transaction, before tax | (40) | (29) | 2 | (18) | (21) | (41) | ||
| Other nonoperating income | 146 | 13 | 42 | 81 | 28 | 3 | ||
| Interest and debt expense | (5) | (0) | (0) | (0) | (2) | |||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 5 | 12,729 | 0 | 48 | 5 | |||
| Income (loss) from continuing operations before income taxes: | (10,675) | 6,364 | (1,194) | 696 | 1,177 | (777) | ||
| Income tax expense (benefit) | 2,014 | (1,802) | (18) | (132) | (266) | 242 | ||
| Income (loss) from continuing operations: | (8,661) | 4,563 | (1,212) | 564 | 911 | (535) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | 4,563 | (1,212) | 564 | 911 | (535) | |
| Net income (loss): | (8,661) | 4,563 | (1,212) | 564 | 911 | (535) | ||
| Other undisclosed net loss attributable to parent | (9,126) | |||||||
| Net income (loss) available to common stockholders, diluted: | (8,661) | (4,563) | (1,212) | 564 | 911 | (535) | ||
Comprehensive Income ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 2/28/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (8,661) | 4,563 | (1,212) | 564 | 911 | (535) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (8,661) | 4,563 | (1,212) | 564 | 911 | (535) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.